We are live on ! Find out more
PM

Penbrook Management Portfolio holdings

AUM $157M
1-Year Est. Return 46.57%
This Fund
S&P 500
This Quarter Est. Return
+11.23%
1 Year Est. Return
+46.57%
3 Year Est. Return
+102.93%
5 Year Est. Return
+150.44%
10 Year Est. Return
AUM
$149M
AUM Growth
+$12.4M
Cap. Flow
+$330K
Cap. Flow %
0.22%
Top 10 Hldgs %
53.42%
Holding
109
New
9
Increased
17
Reduced
49
Closed
5

Sector Composition

Rank Sector Weight
1 Healthcare 25.9%
2 Technology 24.13%
3 Energy 12.64%
4 Financials 11.01%
5 Industrials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AM icon
101
Antero Midstream
AM
$10.4B
$125K 0.08%
10,000
EOSE icon
102
Eos Energy Enterprises
EOSE
$1.36B
$13.6K 0.01%
12,500
PLAB icon
103
PUT
Photronics
PLAB
$1.85B
$314 ﹤0.01%
+10,000
New +$222K
ACLS icon
104
PUT
Axcelis
ACLS
$4.03B
-4,000
Closed -$652
NVVE
105
DELISTED
Nuvve Holding Corp
NVVE
0
-$22K
STKL
106
DELISTED
SunOpta
STKL
-60,065
Closed -$202K
WLY icon
107
John Wiley & Sons Class A
WLY
$2.7B
-5,800
Closed -$216K
CEQP
108
DELISTED
Crestwood Equity Partners LP
CEQP
-34,500
Closed -$1.01M
JPS
109
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
-34,000
Closed -$210K

Similar funds

Penbrook Management's Q4 2023 Portfolio in Review

As of Q4 2023, Penbrook Management held 109 positions worth $149M, up 9.1% from $136M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Penbrook Management's Q4 2023 filing shows 9 new, 17 increased, 49 reduced and 5 closed positions. Its largest new stake was NPK International: 86,835 shares worth $577K. The largest sale was Crestwood Equity Partners LP, an estimated $1.01M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Technology and Energy.

  • Penbrook Management's largest Q4 2023 buy was NPK International: 86,835 shares worth $577K.
  • Penbrook Management added most to Energy Transfer Partners in Q4 2023, an estimated $985K increase.
  • Penbrook Management's biggest Q4 2023 reduction was Novo Nordisk, cutting an estimated $396K.
  • Penbrook Management fully exited Crestwood Equity Partners LP in Q4 2023, selling an estimated $1.01M.
  • Penbrook Management's ten largest holdings make up 53% of its $149M portfolio in Q4 2023.
  • Penbrook Management opened 9 new positions and closed 5 in Q4 2023.
  • Penbrook Management's portfolio value rose 9.1% quarter-over-quarter to $149M.

Based on Penbrook Management's 13F filing for Q4 2023, filed 16 Jan 2024.